Stockscreener 앱 받기
2.2018
4.01%
0.0818
전일 마감가:
$2.12
열려 있는:
$2.14
하루 거래량:
225.06K
Relative Volume:
0.28
시가총액:
$125.34M
수익:
$70.00M
순이익/손실:
$21.50M
주가수익비율:
6.0689
EPS:
0.3628
순현금흐름:
$21.35M
1주 성능:
+1.15%
1개월 성능:
-0.68%
6개월 성능:
-30.44%
1년 성능:
+28.20%
1일 변동 폭
$2.14
$2.23
1주일 범위
$2.07
$2.28
52주 변동 폭
$1.195
$4.94
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
명칭
Black Diamond Therapeutics Inc
전화
617-417-5868
주소
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
Compare BDTX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
2.20 | 120.79M | 70.00M | 21.50M | 21.35M | 0.3628 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.39 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
757.52 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
705.46 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
317.01 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
289.02 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2025-11-18 | 재개 | Piper Sandler | Overweight |
| 2025-10-16 | 재개 | Stifel | Buy |
| 2025-09-04 | 개시 | Guggenheim | Buy |
| 2025-07-01 | 재개 | Raymond James | Outperform |
| 2024-07-31 | 개시 | Raymond James | Outperform |
| 2023-07-14 | 개시 | Piper Sandler | Overweight |
| 2023-06-30 | 업그레이드 | Stifel | Hold → Buy |
| 2023-06-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-06-27 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2022-03-29 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-03-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-09-30 | 개시 | Stifel | Hold |
| 2021-01-07 | 개시 | Wedbush | Outperform |
| 2020-11-24 | 개시 | Berenberg | Buy |
| 2020-05-04 | 개시 | H.C. Wainwright | Buy |
| 2020-02-24 | 개시 | Canaccord Genuity | Buy |
| 2020-02-24 | 개시 | Cowen | Outperform |
| 2020-02-24 | 개시 | JP Morgan | Overweight |
| 2020-02-24 | 개시 | Jefferies | Buy |
모두보기
Black Diamond Therapeutics Inc 주식(BDTX)의 최신 뉴스
Black Diamond Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier - Finviz
Published on: 2026-03-07 03:01:03 - baoquankhu1.vn
Black Diamond Therapeutics Teases Next-Quarter PFS Data for Silevertinib at TD Cowen Conference - MarketBeat
Is BDTX's Cash balance Enough to Successfully Develop Its NSCLC Drug? - MSN
Downgrade Watch: Whats the profit margin of Black Diamond Therapeutics IncWeekly Market Summary & Real-Time Stock Entry Alerts - baoquankhu1.vn
BDTX: Silevertinib demonstrates robust efficacy in NSCLC and is advancing to pivotal GBM trials - TradingView
Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors - Quantisnow
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
Black Diamond Therapeutics Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Clinical-stage oncology firm Black Diamond sets 3 investor events - Stock Titan
Revenue Check: Is Black Diamond Therapeutics Inc a strong growth stock2025 Investor Takeaways & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
BDTX PE Ratio & Valuation, Is BDTX Overvalued - Intellectia AI
Hedge Fund Bets: Is Black Diamond Therapeutics Inc a strong growth stock2025 Key Highlights & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Black Diamond Therapeutics (BDTX) Expected to Announce Quarterly Earnings on Thursday - Defense World
BDTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BDTX SEC FilingsBlack Diamond Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Will Black Diamond Therapeutics Inc. benefit from AI trendsTrade Exit Summary & High Yield Stock Recommendations - mfd.ru
Breakout Zone: What hedge funds are buying Black Diamond Therapeutics IncJuly 2025 Pullbacks & Intraday High Probability Alerts - baoquankhu1.vn
Is Black Diamond Therapeutics Inc. stock undervalued vs historical averagesTrade Entry Summary & Daily Profit Maximizing Trade Tips - mfd.ru
Dividend Watch: Does Capitol Investment Corp VI Debt Equity Composite Units align with a passive investing strategyMarket Movement Recap & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Black Diamond Therapeutics (NASDAQ:BDTX) Stock Price Up 0.5%Here's Why - MarketBeat
Black Diamond Therapeutics (NASDAQ:BDTX) Stock Price Up 0.5% – Here’s Why - Defense World
Dip Buying: Will Black Diamond Therapeutics Inc benefit from AI trendsJuly 2025 Technicals & Reliable Entry Point Alerts - baoquankhu1.vn
Vestal Point holds 1.5% of Black Diamond Therapeutics (BDTX) stock - Stock Titan
Portfolio Update: Is AEVAW a strong candidate for buy and holdMarket Weekly Review & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Does Black Diamond Therapeutics Inc. outperform in volatile marketsEarnings Summary Report & Community Consensus Stock Picks - mfd.ru
Why Black Diamond Therapeutics Inc. stock is popular among millennialsJuly 2025 Review & AI Enhanced Execution Alerts - mfd.ru
BDTX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Can Black Diamond Therapeutics Inc. reach all time highs this year2025 Valuation Update & Weekly High Potential Stock Alerts - mfd.ru
What is Black Diamond Therapeutics Inc. s revenue forecast2025 Risk Factors & High Accuracy Buy Signal Tips - mfd.ru
Black Diamond Therapeutics, Inc. (BDTX) price target trimmed as Piper updates biotech models and 2026 catalyst tracker - MSN
Will Black Diamond Therapeutics Inc. stock sustain high P E ratiosExit Point & Daily Profit Focused Screening - mfd.ru
Black Diamond Therapeutics, Inc. (BDTX) Price Target Trimmed as Piper Updates Biotech Models and 2026 Catalyst Tracker - Finviz
Dow Update: What is Black Diamond Therapeutics Incs revenue forecast2025 Biggest Moves & Daily Growth Stock Investment Tips - baoquankhu1.vn
What’s the profit margin of Black Diamond Therapeutics Inc.Take Profit & Safe Entry Zone Tips - mfd.ru
Convergent Therapeutics Appoints Elizabeth L. Montgomery Chief People Officer - BioSpace
How much upside does Black Diamond Therapeutics Inc. haveJuly 2025 Big Picture & Detailed Earnings Play Strategies - mfd.ru
Entry Recap: Can Black Diamond Therapeutics Inc maintain sales growthRate Cut & Precise Swing Trade Alerts - baoquankhu1.vn
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Aug Reactions: Does Black Diamond Therapeutics Inc outperform in volatile markets2025 Key Highlights & Expert Approved Trade Ideas - baoquankhu1.vn
Growth Review: Is Black Diamond Therapeutics Inc stock good for income investorsEarnings Beat & High Conviction Trade Alerts - baoquankhu1.vn
Is Black Diamond Therapeutics (BDTX) stock outpacing its medical peers this year? - MSN
Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Aug Patterns: Does Black Diamond Therapeutics Inc outperform in volatile marketsJuly 2025 Earnings & Precise Swing Trade Alerts - baoquankhu1.vn
Market Review: Whats the profit margin of Black Diamond Therapeutics IncEarnings Performance Report & Real-Time Buy Signal Notifications - baoquankhu1.vn
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Down 39.9% in December - Defense World
Piper Sandler Maintains Rating but Lowers Price Target for BDTX | BDTX Stock News - GuruFocus
Declining Stock and Solid Fundamentals: Is The Market Wrong About Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)? - Yahoo Finance
Growth Value: What is the long term forecast for MPLX LP Limited Partnership stockJuly 2025 Big Picture & Weekly Chart Analysis and Guides - baoquankhu1.vn
Black Diamond Therapeutics Inc (BDTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.65%
0.04%
자본화:
|
볼륨(24시간):